Inventor · disambiguated record
Moses Rodriguez
Also filed as: RODRIGUEZ MOSES
25 granted patents·17 pending applications·340 citations·filing 1994–2022
96Inventor score
Files withMAYO FOUNDATION13MAYO FOUND MEDICAL EDUCATION & RES8RODRIGUEZ MOSES6PEASE LARRY R4ACORDA THERAPEUTICS INC1
Top patents by PatentIndex Score
42 records- 0195US7807166B2Methods of promoting remyelination of central nervous system axons by administrating sHIgM22MAYO FOUNDATION·Filed 2008·Granted Oct 5, 2010·14 cites·34 claims
- 0295US7390888B2Dendritic cell potentiationMAYO FOUNDATION·Filed 2005·Granted Jun 24, 2008·37 cites·3 claims
- 0392US7473423B2Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous systemMAYO FOUNDATION·Filed 2001·Granted Jan 6, 2009·28 cites·8 claims
- 0492US7052694B2Dendritic cell potentiationMAYO FOUNDATION·Filed 2002·Granted May 30, 2006·47 cites·21 claims
- 0592US6800285B2Treatment of central nervous system diseases by antibodies against glatiramer acetateFiled 2001·Granted Oct 5, 2004·60 cites·14 claims
- 0691US9260512B2Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous systemRODRIGUEZ MOSES·Filed 2013·Granted Feb 16, 2016·6 cites·23 claims
- 0789US8420795B2Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous systemRODRIGUEZ MOSES·Filed 2010·Granted Apr 16, 2013·11 cites·21 claims
- 0885US5591629AMonoclonal antibodies which promote central nervous system remyelinationMAYO FOUNDATION·Filed 1994·Granted Jan 7, 1997·51 cites·2 claims
- 0982US9150867B2DNA aptamers for promoting remyelinationMAHER III LOUIS J·Filed 2012·Granted Oct 6, 2015·5 cites·10 claims
- 1079US9809823B2DNA aptamers for promoting remyelinationMAYO FOUNDATION·Filed 2016·Granted Nov 7, 2017·1 cites·10 claims
- 1178US9481887B2DNA aptamers for promoting remyelinationMAYO FOUNDATION·Filed 2015·Granted Nov 1, 2016·2 cites·11 claims
- 1277US10351620B2Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous systemRODRIGUEZ MOSES·Filed 2017·Granted Jul 16, 2019·1 cites·20 claims
- 1375US2010009438A1Dendritic cell potentiationPEASE LARRY R·Filed 2009·Application pending·0 cites
- 1473US5863529ASuppression of demyelination by interleukin-6MAYO FOUNDATION·Filed 1995·Granted Jan 26, 1999·37 cites·7 claims
- 1572US8968735B2Compositions and methods including a recombinant human MAB that promotes CNS remyelinationACORDA THERAPEUTICS INC·Filed 2013·Granted Mar 3, 2015·2 cites·13 claims
- 1672US2022251157A1IgM-MEDIATED RECEPTOR CLUSTERING AND CELL MODULATIONMAYO FOUND MEDICAL EDUCATION & RES·Filed 2022·Application pending·0 cites
- 1772US2020247883A1Compositions and methods including a recombinant human mab that promotes cns remyelinationMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Application pending·0 cites
- 1871US9421242B2Methods and materials for reducing the severity of viral infectionsMAYO FOUNDATION·Filed 2014·Granted Aug 23, 2016·1 cites·7 claims
- 1970US7754216B2Method of treating multiple sclerosis with anti-K6 antibodyMAYO FOUNDATION·Filed 2003·Granted Jul 13, 2010·5 cites·4 claims
- 2069US11274131B2IgM-mediated receptor clustering and cell modulationMAYO FOUND MEDICAL EDUCATION & RES·Filed 2018·Granted Mar 15, 2022·0 cites·8 claims
- 2167US10202430B2IgM-mediated receptor clustering and cell modulationPEASE LARRY R·Filed 2008·Granted Feb 12, 2019·0 cites·3 claims
- 2267US5660828AMethod of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cellsMAYO FOUNDATION·Filed 1994·Granted Aug 26, 1997·32 cites·9 claims
- 2366US2010015163A1Dendritic cell potentiationPEASE LARRY R·Filed 2009·Application pending·0 cites
- 2465US2008193467A1Dendritic cell potentiationPEASE LARRY R·Filed 2008·Application pending·0 cites
- 2558US9701745B2Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous systemRODRIGUEZ MOSES·Filed 2016·Granted Jul 11, 2017·0 cites·13 claims
- 2658US2020397898A1Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological diseaseMAYO FOUND MEDICAL EDUCATION & RES·Filed 2020·Application pending·0 cites
- 2756US2011065178A1Dendritic cell potentiationMAYO FOUNDATION·Filed 2010·Application pending·0 cites
- 2855US9981019B2Methods and materials for reducing the severity of viral infectionsMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted May 29, 2018·0 cites·9 claims
- 2955US2018179277A1Compositions and Methods including a Recombinant Human MAB that Promotes CNS RemyelinationMAYO FOUNDATION FOR MEDICAL EDUCATION & RES·Filed 2017·Application pending·0 cites
- 3055US2022135659A1Treatment of neonatal hypoxia including impairments or effects thereofMAYO FOUND MEDICAL EDUCATION & RES·Filed 2021·Application pending·0 cites
- 3153US12037590B2Short DNA aptamers and methods for promoting remyelinationMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted Jul 16, 2024·0 cites·16 claims
- 3250US2013323262A1Methods and materials for treating inflammatory conditionsRES MAYO FOUNDATION FOR MEDICAL EDUCATION AND·Filed 2013·Application pending·0 cites
- 3350US2011027288A1Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agentsRODRIGUEZ MOSES·Filed 2009·Application pending·0 cites
- 3450US2005019322A1Treatment of central nervous system diseases by antibodies against glatiramer acetateFiled 2004·Application pending·0 cites
- 3547US8460665B2Compositions and methods including a recombinant human MAB that promotes CNS remyelinationGRUSKIN ELLIOT A·Filed 2004·Granted Jun 11, 2013·0 cites·14 claims
- 3646US9751943B2Compositions and methods including a recombinant human MAB that promotes CNS remyelinationMAYO FOUND FOR MEDICAL EDUCATION & RES·Filed 2015·Granted Sep 5, 2017·0 cites·18 claims
- 3745US2013280167A1Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological diseaseRODRIGUEZ MOSES·Filed 2011·Application pending·0 cites
- 3841US11180543B2Treatment of neonatal hypoxia including impairments or effects thereofMAYO FOUND MEDICAL EDUCATION & RES·Filed 2015·Granted Nov 23, 2021·0 cites·15 claims
- 3941US2015104460A1Human Antibodies and Specific Binding Sequences Thereof for use in Stroke and Ischemia or Ischemic ConditionsMAYO FOUNDATION·Filed 2013·Application pending·0 cites
- 4040US2011008789A1Methods and materials for treating inflammatory conditionsSCARISBRICK ISOBEL A·Filed 2010·Application pending·0 cites
- 4138US2006140930A1Promotion of central nervous system remyelination using monoclonal autoantibodiesMAYO FOUNDATION FOR MEDICAL RE·Filed 2005·Application pending·0 cites
- 4223US2002164325A1Promotion of central nervous system remyelination using monoclonal autoantibodiesFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Moses Rodriguez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →